Sponsor:
University of Colorado, Denver
Code:
NCT07120295
Conditions
Bile Duct Adenocarcinoma
Bile Duct Carcinoma
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
Dragonfly™ Digital Pancreaticobiliary System
Brief summary:
Conditions
Bile Duct Adenocarcinoma
Bile Duct Carcinoma
Study ID
NCT07120295
Start date
Aug 11, 2025
Status verified date
Sep, 2026
Completion date
Dec, 2028
Anticipated
Primary completion date
Dec, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Enrollment
75 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Interventional Group
Interventions
Dragonfly™ Digital Pancreaticobiliary System
Primary outcome measure
Central contacts
Locations
Universtiy of Colorado Hospital
Recruiting
Aurora, Colorado, United States, 80045
Contacts
Principal Investigator:
Raj Shah, MD
Sponsor
University of Colorado, Denver
Last update posted
Sep 3, 2026
Last verified
Sep, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2026-09-03.